Cargando…
Broadly neutralizing antibodies against COVID-19
The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an effective treatment. Since SARS-CoV-2 emerged, a variety of strains have acquired increasing numbers of mutations to gain increased t...
Autores principales: | Zhou, Daming, Ren, Jingshan, Fry, Elizabeth E, Stuart, David I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301462/ https://www.ncbi.nlm.nih.gov/pubmed/37285620 http://dx.doi.org/10.1016/j.coviro.2023.101332 |
Ejemplares similares
-
Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017) -
Target Identification
and Mode of Action of Four Chemically
Divergent Drugs against Ebolavirus Infection
por: Ren, Jingshan, et al.
Publicado: (2017) -
Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
por: Wilmschen, Sarah, et al.
Publicado: (2019) -
Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014) -
The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus
por: Ren, Jingshan, et al.
Publicado: (2019)